Omnicell (OMCL) Tops Q3 EPS by 15c ; Offers Guidance

Omnicell (NASDAQ: OMCL) reported Q3 EPS of $0.51, $0.15 better than the analyst estimate of $0.36. Revenue for the quarter came in at $310.63 million versus the consensus estimate of $295.6 million.

GUIDANCE:

Omnicell sees Q4 2025 EPS of $0.40-$0.50, versus the consensus of $0.48. Omnicell sees Q4 2025 revenue of $306-316 million, versus the consensus of $295.3 million.

Omnicell sees FY2025 EPS of $1.63-$1.73, versus the consensus of $1.55. Omnicell sees FY2025 revenue of $1.17-1.18 billion, versus the consensus of $1.19 billion.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Select Medical stockholders approve buyout by insider-led consortium
• AES stockholders approve $10.7 billion takeover by GIP and EQT